Hugh Gannon - Concepedia

Concepedia

Author

Hugh Gannon

University of Massachusetts Chan Medical School ORCID

Also Known As

Gannon, Hugh S., H. S. Gannon, Hugh Gannon, Hugh S. Gannon, Hugh S. Gannon

51

Publications

1.3K

Citations

12

H-Index

33

Concepts

All Affiliations

University of Massachusetts Chan Medical School Dana-Farber Cancer Institute Harvard University Broad Institute

HG

About

Hugh Gannon is an author at University of Massachusetts Chan Medical School specializing in medicine, cell biology, and genome instability.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	816
2	Cell Biology	5	5	250
3	Health Sciences	1	1	566
4	Natural Sciences	1	1	98
5	Immunology	1	1	30

Hugh Gannon

×

12

Publications

1.3K

Citations

12

H-Index

	Year	Citations
Mutational processes shape the landscape of TP53 mutations in human cancer Andrew O. Giacomelli, Xiaoping Yang, Robert Lintner, Nature Genetics Genome InstabilitySomatic VariantTumor HeterogeneityMutational ProcessesCancer Genomics	2018	566
Identification of ADAR1 adenosine deaminase dependency in a subset of cancer cells Hugh Gannon, Tao Zou, Michael K. Kießling, Nature Communications	2018	244
ATM Phosphorylation of Mdm2 Ser394 Regulates the Amplitude and Duration of the DNA Damage Response in Mice Hugh Gannon, Bruce A. Woda, Stephen N. Jones Cancer Cell Knockout MouseChromatinGenome InstabilityAtm PhosphorylationMdm2 Ser394	2012	98
Mdm2–p53 signaling regulates epidermal stem cell senescence and premature aging phenotypes in mouse skin Hugh Gannon, Lawrence A. Donehower, Stephen Lyle, Developmental Biology Skin DevelopmentLongevityMedicineCutaneous BiologyStem Cell Research	2011	84
Inhibitor of growth-4 promotes IκB promoter activation to suppress NF-κB signaling and innate immunity Andrew H. Coles, Hugh Gannon, Anna Cerny, Proceedings of the National Academy of Sciences	2010	56
Aerobic Glycolysis Suppresses p53 Activity to Provide Selective Protection from Apoptosis upon Loss of Growth Signals or Inhibition of BCR-Abl Emily F. Mason, Yuxing Zhao, Pankuri Goraksha-Hicks, Cancer Research	2010	47
The USP1 Inhibitor KSQ-4279 Overcomes PARP Inhibitor Resistance in Homologous Recombination–Deficient Tumors Louise Cadzow, Jehrod Brenneman, Erica R. Tobin, Cancer Research	2024	34
Mdm2 Phosphorylation Regulates Its Stability and Has Contrasting Effects on Oncogene and Radiation-Induced Tumorigenesis Michael I. Carr, Justine E. Roderick, Hugh Gannon, Cell Reports	2016	31
Identification of an “Exceptional Responder” Cell Line to MEK1 Inhibition: Clinical Implications for MEK-Targeted Therapy Hugh Gannon, Nathan O. Kaplan, Aviad Tsherniak, Molecular Cancer Research	2015	30
Rational design of a SOCS1-edited tumor-infiltrating lymphocyte therapy using CRISPR/Cas9 screens Michael R. Schlabach, Sharon Lin, Zachary R. Collester, Journal of Clinical Investigation Cancer ImmunosurveillanceCrispr/cas9 ScreensComprehensive CrisprRational DesignSocs1 Gene	2023	30

Page 1